Why the study?
Does oral acyclovir improve the duration and severity of chickenpox in otherwise healthy children and adolescents?
Does oral acyclovir improve the duration and severity of chickenpox in otherwise healthy children and adolescents?
Answers are grounded in this paper and cite their sources.
While acyclovir effectively reduces the duration and severity of chickenpox, its routine use in all healthy children is debated due to cost and dosing inconvenience, though it is strongly supported for secondary household cases and immunocompromised patients.
no evidence at present to suggest that resistant strains of varicella zoster virus will occur in the immuno- competent community with antiviral use, but this will need to be monitored.Resistance has occurred rarely in immunocompromised patients with varicella zoster virus infection; prolonged viral replication in these patients provides an optimum environment for selection of resistant strains.The mildness and self limiting nature of chickenpox is confirmed by the placebo groups in the American studies.Though an argument can be made for treating secondary and tertiary cases and adults with acyclovir as well as any immunocompromised patient, the modest clinical benefit from what would be a very costly programme do not support the routine treatment of chickenpox in normal healthy children.1 Preblud SR.Age specific risks of varicella complications.
No takes yet. Share an insight, caveat, or question.
Henry H. Balfour (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: